Schalkwijk C - Search Results

1

Genetically proxied ketohexokinase function and risk of colorectal cancer: a Mendelian randomisation study.

Buziau AM, Law PJ, Blokland G, Schalkwijk C, Scheijen J, Simons P, van der Kallen C, Eussen S, Dagnelie PC, van Greevenbroek M, Houlston RS, Wesselius A, Went M, Stehouwer C, Brouwers MC. Buziau AM, et al. Among authors: schalkwijk c. Gut. 2023 Mar;72(3):604-606. doi: 10.1136/gutjnl-2021-326299. Epub 2022 May 10. Gut. 2023. PMID: 35537810 No abstract available.

2

[No title available]

[No authors listed] [No authors listed] PMID: 36027326

3

[No title available]

[No authors listed] [No authors listed] PMID: 36027327

4

Metformin use in type 2 diabetic patients is not associated with lower arterial stiffness: the Maastricht Study.

Driessen JHM, de Vries F, van Onzenoort HAW, Schram MT, van der Kallen C, Reesink KD, Sep S, Stehouwer CDA, Schaper N, Kroon AA, Schalkwijk C, van den Bergh JPW, Henry RMA. Driessen JHM, et al. Among authors: schalkwijk c. J Hypertens. 2019 Feb;37(2):365-371. doi: 10.1097/HJH.0000000000001892. J Hypertens. 2019. PMID: 30640873

5

N epsilon-(carboxymethyl)lysine during the early development of hypertension.

Baumann M, Stehouwer C, Scheijen J, Heemann U, Struijker Boudier H, Schalkwijk C. Baumann M, et al. Among authors: schalkwijk c. Ann N Y Acad Sci. 2008 Apr;1126:201-4. doi: 10.1196/annals.1433.004. Epub 2007 Dec 13. Ann N Y Acad Sci. 2008. PMID: 18079484

6

C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification.

Colhoun HM, Schalkwijk C, Rubens MB, Stehouwer CD. Colhoun HM, et al. Among authors: schalkwijk c. Diabetes Care. 2002 Oct;25(10):1813-7. doi: 10.2337/diacare.25.10.1813. Diabetes Care. 2002. PMID: 12351483

7

Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: Post hoc analysis of a randomized controlled 4.3year trial.

Out M, Kooy A, Lehert P, Schalkwijk CA, Stehouwer CDA. Out M, et al. J Diabetes Complications. 2018 Feb;32(2):171-178. doi: 10.1016/j.jdiacomp.2017.11.001. Epub 2017 Nov 8. J Diabetes Complications. 2018. PMID: 29174300

8

MicroRNA-126 and micro-/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study.

Barutta F, Bruno G, Matullo G, Chaturvedi N, Grimaldi S, Schalkwijk C, Stehouwer CD, Fuller JH, Gruden G. Barutta F, et al. Among authors: schalkwijk c. Acta Diabetol. 2017 Feb;54(2):133-139. doi: 10.1007/s00592-016-0915-4. Epub 2016 Oct 1. Acta Diabetol. 2017. PMID: 27696070 Free article.

9

Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study.

Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study. Schram MT, et al. Among authors: schalkwijk c. Diabetes Care. 2003 Jul;26(7):2165-73. doi: 10.2337/diacare.26.7.2165. Diabetes Care. 2003. PMID: 12832330

10

Association between bone metabolism regulators and arterial stiffness in type 2 diabetes patients.

Sharif S, Bots ML, Schalkwijk C, Stehouwer CDA, Visseren FLJ, Westerink J; SMART study group. Sharif S, et al. Among authors: schalkwijk c. Nutr Metab Cardiovasc Dis. 2018 Dec;28(12):1245-1252. doi: 10.1016/j.numecd.2018.06.004. Epub 2018 Jun 13. Nutr Metab Cardiovasc Dis. 2018. PMID: 30017437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

521 results

Search Page